A recent study investigates whether apixaban is superior to aspirin in preventing nonlacunar covert infarcts in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback